Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

Subjects: ECULIZUMAB; PAROXYSMAL hemoglobinuria; DRUG efficacy

  • Source: New England Journal of Medicine. 3/18/2021, Vol. 384 Issue 11, p1028-1037. 10p.

Record details

×

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

  • Source: The New England journal of medicine [N Engl J Med] 2024 Mar 14; Vol. 390 (11), pp. 1060.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Eculizumab in Atypical Hemolytic-Uremic Syndrome.

Subjects: COMPLEMENT inhibition; ECULIZUMAB; HEMOLYTIC-uremic syndrome

  • Source: New England Journal of Medicine. 10/3/2013, Vol. 369 Issue 14, p1377-1380. 4p.

Record details

×
Academic Journal

Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy.

Subjects: ECULIZUMAB; CD55 antigen; INTESTINAL diseases

  • Source: New England Journal of Medicine. 7/6/2017, Vol. 377 Issue 1, following p98-98. 3p.

Record details

×
Academic Journal

Eculizumab for the Treatment of Dense-Deposit Disease.

Subjects: ECULIZUMAB; PROTEINURIA; BLOOD proteins

  • Source: New England Journal of Medicine. 3/22/2012, Vol. 366 Issue 12, p1163-1165. 3p. 1 Diagram.

Record details

×
Academic Journal

Eculizumab in a Patient with Dense-Deposit Disease.

Subjects: ECULIZUMAB; SERUM; PROTEINS

  • Source: New England Journal of Medicine. 3/22/2012, Vol. 366 Issue 12, p1161-1163. 3p. 1 Diagram.

Record details

×
Editorial & Opinion

Pegcetacoplan versus Eculizumab in PNH. Reply.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Hemoglobinuria, Paroxysmal*/Hemoglobinuria, Paroxysmal*/Hemoglobinuria, Paroxysmal*/drug therapy; Humans

  • Source: The New England journal of medicine [N Engl J Med] 2021 Oct 28; Vol. 385 (18), pp. 1725-1726.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Pegcetacoplan versus Eculizumab in PNH.

  • Authors : Ueda Y; Osaka University Graduate School of Medicine, Osaka, Japan .; Takamori H

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Hemoglobinuria, Paroxysmal*/Hemoglobinuria, Paroxysmal*/Hemoglobinuria, Paroxysmal*/drug therapy; Humans

  • Source: The New England journal of medicine [N Engl J Med] 2021 Oct 28; Vol. 385 (18), pp. 1723-1724.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  188 results for ""ECULIZUMAB""